Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-49
Closed -$2.99K 3256
2016
Q1
$3K Sell
49
-9,258
-99% -$516K ﹤0.01% 3270
2015
Q4
$551K Sell
9,307
-31,339
-77% -$1.81M 0.01% 1857
2015
Q3
$2.21M Buy
+40,646
New +$2.65M 0.02% 1014
2015
Q2
Sell
-42,188
Closed -$2.75M 3806
2015
Q1
$2.47M Buy
+42,188
New +$2.55M 0.02% 972
2014
Q4
Sell
-130,591
Closed -$8.23M 3951
2014
Q3
$7.54M Buy
130,591
+35,216
+37% +$1.96M 0.04% 681
2014
Q2
$5.38M Buy
95,375
+27,338
+40% +$1.43M 0.03% 904
2014
Q1
$3.5M Sell
68,037
-1,083
-2% -$54.7K 0.02% 1070
2013
Q4
$3.65M Sell
69,120
-41,440
-37% -$2.04M 0.02% 1099
2013
Q3
$4.95M Buy
110,560
+15,549
+16% +$689K 0.03% 722
2013
Q2
$3.93M Buy
+95,011
New +$4.16M 0.02% 869

Other funds holding ABBV

Spot Trading's ABBV Position: Q2 2016 in Review

Spot Trading sold out of AbbVie (ABBV) in Q2 2016, closing a stake of 49 shares — an estimated $2.99K sold.

Spot Trading first reported a position in ABBV in Q2 2013 and held it in 10 quarters. The position peaked at $7.54M in Q3 2014. 1,636 funds tracked by Wall St. Rank hold ABBV as of Q2 2016.

  • Spot Trading reported no remaining AbbVie position as of Q2 2016 after selling out during the quarter.
  • Spot Trading sold 49 AbbVie shares in Q2 2016, an estimated $2.99K.
  • Spot Trading first reported a position in AbbVie in Q2 2013 and held it in 10 quarters.
  • Spot Trading's AbbVie position peaked at $7.54M in Q3 2014.
  • 1,636 funds tracked by Wall St. Rank held AbbVie as of Q2 2016.

Based on Spot Trading's 13F filing for Q2 2016, filed 2 Aug 2016.